Processa Pharmaceuticals, Inc. (PCSA): 14 insider purchases in the last two years (2 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jun 16, 2026 | Young David Director, Officer | 2,067 | $2.22 | $4.6K | opportunistic |
| Jun 16, 2026 | Skibsted Russell Officer | 2,654 | $2.22 | $5.9K | no history |
| Jun 16, 2026 | Ng George K Director, Officer | 2,465 | $2.22 | $5.5K | no history |
| Jun 16, 2026 | Lin Patrick Officer | 1,831 | $2.22 | $4.1K | no history |
| Jun 16, 2026 | Guy Wendy Officer | 2,118 | $2.22 | $4.7K | no history |
| Jun 1, 2026 | Young David Director, Officer | 1,786 | $2.57 | $4.6K | opportunistic |
| Jun 1, 2026 | Skibsted Russell Officer | 2,292 | $2.57 | $5.9K | no history |
| Jun 1, 2026 | Ng George K Director, Officer | 2,129 | $2.57 | $5.5K | no history |
| Jun 1, 2026 | Lin Patrick Officer | 1,582 | $2.57 | $4.1K | no history |
| Jun 1, 2026 | Guy Wendy Officer | 1,829 | $2.57 | $4.7K | no history |
| Jan 31, 2025 | Yorke Justin W Director | 12,400 | $0.80 | $9.9K | no history |
| Jan 29, 2025 | Lin Patrick Officer | 43,500 | $0.80 | $34.8K | no history |
| Jan 29, 2025 | Young David Director, Officer | 124,500 | $0.80 | $99.6K | no history |
| Jan 29, 2025 | Ng George K Director, Officer | 87,200 | $0.80 | $69.8K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.